Skip to Content

Psychological Distress High Among Students During COVID-19

TUESDAY, Feb. 2, 2021 -- The prevalence of self-reported psychological distress among students has been relatively high during the COVID-19 pandemic, according to a study published online Jan. 26 in JAMA Network Open.

Zuguo Qin, M.P.H., from the Health Publicity and Education Center of Guangdong Province in Guangzhou, China, and colleagues conducted a cross-sectional study using data from a survey of children in Guangdong province, China, to examine self-reported psychological distress associated with COVID-19, measured using the total score on the 12-item General Health Questionnaire. Data were included for 1,199,320 students (mean age, 12.04 years).

The researchers found that 10.5 percent of the students self-reported psychological distress. High school students had an increased risk for psychological distress compared with students in primary school (odds ratio, 1.19). Students who never wore a face mask had an increased risk for psychological distress compared with those who wore a face mask frequently (odds ratio, 2.59). Compared with students who spent more than one hour exercising, those who spent less than 0.5 hours exercising had increased odds of self-reported psychological distress (odds ratio, 1.64).

"Based on these findings, it is necessary for governments, schools, and families to pay attention to the mental health of school-aged children and adolescents during the COVID-19 pandemic and take appropriate countermeasures to reduce the impact of the COVID-19 pandemic on mental health for children and adolescents," the authors write.

Abstract/Full Text

© 2021 HealthDay. All rights reserved.

Posted: February 2021

Read this next

Walmart Expands COVID-19 Vaccination Program

MONDAY, March 1, 2021 -- Walmart said it will expand its COVID-19 vaccination program to more than 1,400 pharmacies in 35 states. The retailer will also partner with local...

AstraZeneca COVID-19 Vaccine Easy to Update in Response to Variants

MONDAY, March 1, 2021 -- A COVID-19 vaccine still awaiting U.S. Food and Drug Administration approval may prove to be a powerful weapon in fighting the pandemic, according to its...

J&J COVID-19 Vaccine Granted Emergency Use Authorization

MONDAY, March 1, 2021 -- The Janssen COVID-19 vaccine received the third emergency use authorization for a vaccine to prevent COVID-19, the U.S. Food and Drug Administration...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.